Hedvig Zetterberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hedvig Zetterberg has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Hanna Ljungvall
Department of Women’s and Children’s Health, Physiotherapy and Behavioral Medicine, Uppsala University, Uppsala, Sweden
2 shared publications Katja Boersma
Center for Health and Medical Psychology, School of Behavioral, Social, and Legal Sciences Örebro University Örebro Sweden
2 shared publications- Pernilla Åsenlöf
Department of Women’s and Children’s Health, Physiotherapy and Behavioral Medicine, Uppsala University, Uppsala, Sweden
2 shared publications Anneli Peolsson
Department of Health Medicine and Caring Sciences, Unit of Physiotherapy, Linköping University , Linköping, SE-581 83
1 shared publication- Annika Bring
Uppsala University
1 shared publication Charlotte de Belder Tesséus
Department of Neuroscience , Uppsala University , Uppsala , Sweden
1 shared publication
Latest Publications
- Open Access
- 13 June 2026
- Published by Wiley in European journal of pain
- Vol. 30 (6) , e70310
Effectiveness of a Transdiagnostic Emotion‐Focused Treatment in Clinical Care: A Sequential Single‐Case Experimental Design
Background: Chronic pain frequently co‐occurs with emotional problems, highlighting the need for integrated treatment approaches. Previously, we evaluated a hybrid emotion‐focused treatment with positive results. However, there is a dire need for studies evaluating treatments in ‘real world’ clinical contexts. Therefore, this study evaluated the effectiveness of this treatment in regular clinical care. Methods: Using a sequential single‐case experimental AB design with randomized baseline lengths (4, 5 or 6 weeks), pain, emotional problems and cognitive behavioural factors were assessed weekly across a 20‐week study period. Additional outcome measurements were collected at pre‐, post‐ and 12‐month follow‐up. Patients from primary and secondary care (final n = 31) with chronic pain and anxiety/depression were recruited, and their psychologists delivered the treatment. Individual effects were evaluated using non‐overlap of all pairs and aggregated effects via multilevel shift models. Acceptability, adherence and fidelity were summarized, and responders and non‐responders compared using group‐level analyses. Results: Most (87%) demonstrated a treatment response on ≥ 1 outcome, and over half (55%) on ≥ 3 outcomes. One‐third were classified as broad responders. Aggregated analysis showed a significant effect on pain interference. The treatment was viewed as credible and acceptable, with greater satisfaction among responders. Non‐responders showed more variability in attendance and lower progression through later treatment phases involving exposure. Conclusion: The findings support the feasibility and potential effectiveness of the hybrid emotion‐focused treatment for patients in routine clinical care. The treatment benefits most patients to some extent and a smaller subset of patients to a clinically significant extent. Significance Statement: This pragmatic trial evaluates effectiveness in a clinically representative patient sample reflecting the complexity of routine care, including pain and psychiatric comorbidity, sociodemographic diversity and health care utilization. The hybrid emotion‐focused treatment represents one of several emerging approaches targeting pain–emotion connections. These findings extend results from a prior RCT and highlight the importance of evaluating interventions under real‐world clinical conditions.
- 13 June 2026
- Published by Wiley in European journal of pain
- Vol. 30 (6) , e70310
Open AccessEffectiveness of a Transdiagnostic Emotion‐Focused Treatment in Clinical Care: A Sequential Single‐Case Experimental Design
Background: Chronic pain frequently co‐occurs with emotional problems, highlighting the need for integrated treatment approaches. Previously, we evaluated a hybrid emotion‐focused treatment with positive results. However, there is a dire need for studies evaluating treatments in ‘real world’ clinical contexts. Therefore, this study evaluated the effectiveness of this treatment in regular clinical care. Methods: Using a sequential single‐case experimental AB design with randomized baseline lengths (4, 5 or 6 weeks), pain, emotional problems and cognitive behavioural factors were assessed weekly across a 20‐week study period. Additional outcome measurements were collected at pre‐, post‐ and 12‐month follow‐up. Patients from primary and secondary care (final n = 31) with chronic pain and anxiety/depression were recruited, and their psychologists delivered the treatment. Individual effects were evaluated using non‐overlap of all pairs and aggregated effects via multilevel shift models. Acceptability, adherence and fidelity were summarized, and responders and non‐responders compared using group‐level analyses. Results: Most (87%) demonstrated a treatment response on ≥ 1 outcome, and over half (55%) on ≥ 3 outcomes. One‐third were classified as broad responders. Aggregated analysis showed a significant effect on pain interference. The treatment was viewed as credible and acceptable, with greater satisfaction among responders. Non‐responders showed more variability in attendance and lower progression through later treatment phases involving exposure. Conclusion: The findings support the feasibility and potential effectiveness of the hybrid emotion‐focused treatment for patients in routine clinical care. The treatment benefits most patients to some extent and a smaller subset of patients to a clinically significant extent. Significance Statement: This pragmatic trial evaluates effectiveness in a clinically representative patient sample reflecting the complexity of routine care, including pain and psychiatric comorbidity, sociodemographic diversity and health care utilization. The hybrid emotion‐focused treatment represents one of several emerging approaches targeting pain–emotion connections. These findings extend results from a prior RCT and highlight the importance of evaluating interventions under real‐world clinical conditions.
- Open Access
- 23 December 2025
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 27 (7) , 794-803
Efficacy of neck-specific exercises with and without internet-based support on psychological factors in chronic whiplash-associated disorders: secondary analyses of a randomized controlled trial
Objective: Chronic whiplash-associated disorders (WAD) can involve complex interactions between physical symptoms and psychological factors, and long-term effects of exercise programs are of interest. This study aimed to evaluate the effects of a predominantly internet-based neck-specific exercise program (NSEIT) compared with the same neck-specific exercises (NSE) performed at a physiotherapy clinic on psychological outcomes in chronic WAD, including cognitive-behavioral factors (pain catastrophizing, fear-avoidance beliefs, self-efficacy), emotional distress (symptoms of depression, anxiety), and cognitive functioning. A further objective was to assess whether psychological factors moderated treatment effects on the primary outcome, neck-specific disability. Methods: This secondary analysis was based on a randomized multicenter trial. Participants (n = 140) were randomized to NSEIT or NSE. Outcomes were assessed at baseline, 3 months, and 15 months. Psychological outcomes were analyzed with mixed-design analysis of variance. Moderation effects were tested by adding interaction terms (psychological factor×group) in linear regression models of neck-specific disability. Results: No significant group differences or group×time interactions were found for psychological outcomes. However, there were significant main effects of time for cognitive-behavioral factors and emotional distress in both groups (all P < .01), with small to intermediate effect sizes. Psychological factors did not moderate the treatment effects on neck-specific disability. Conclusion: The internet-based format (NSEIT), involving fewer clinical visits, did not differ from the more comprehensive physiotherapist-led program (NSE) with regard to psychological outcomes. Improvements in cognitive-behavioral factors and emotional distress occurred over time in both groups. The internet-based format might be suitable regardless of psychological characteristics at baseline. Clinical trial registration: www.ClinicalTrials.gov ID: NCT03022812 (December 20, 2016).
- 23 December 2025
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 27 (7) , 794-803
Open AccessEfficacy of neck-specific exercises with and without internet-based support on psychological factors in chronic whiplash-associated disorders: secondary analyses of a randomized controlled trial
Objective: Chronic whiplash-associated disorders (WAD) can involve complex interactions between physical symptoms and psychological factors, and long-term effects of exercise programs are of interest. This study aimed to evaluate the effects of a predominantly internet-based neck-specific exercise program (NSEIT) compared with the same neck-specific exercises (NSE) performed at a physiotherapy clinic on psychological outcomes in chronic WAD, including cognitive-behavioral factors (pain catastrophizing, fear-avoidance beliefs, self-efficacy), emotional distress (symptoms of depression, anxiety), and cognitive functioning. A further objective was to assess whether psychological factors moderated treatment effects on the primary outcome, neck-specific disability. Methods: This secondary analysis was based on a randomized multicenter trial. Participants (n = 140) were randomized to NSEIT or NSE. Outcomes were assessed at baseline, 3 months, and 15 months. Psychological outcomes were analyzed with mixed-design analysis of variance. Moderation effects were tested by adding interaction terms (psychological factor×group) in linear regression models of neck-specific disability. Results: No significant group differences or group×time interactions were found for psychological outcomes. However, there were significant main effects of time for cognitive-behavioral factors and emotional distress in both groups (all P < .01), with small to intermediate effect sizes. Psychological factors did not moderate the treatment effects on neck-specific disability. Conclusion: The internet-based format (NSEIT), involving fewer clinical visits, did not differ from the more comprehensive physiotherapist-led program (NSE) with regard to psychological outcomes. Improvements in cognitive-behavioral factors and emotional distress occurred over time in both groups. The internet-based format might be suitable regardless of psychological characteristics at baseline. Clinical trial registration: www.ClinicalTrials.gov ID: NCT03022812 (December 20, 2016).
- Open Access
- 19 July 2025
- Published by Wiley in European journal of pain
- Vol. 29 (7) , e70081
Opioid Use and Prescription Opioid Use Disorder: Biopsychosocial Characterisation of a Clinical Chronic Pain Cohort
Background: This study aimed to examine: (a) characteristics associated with long‐term opioid use and (b) characteristics associated with problematic opioid use, here defined as prescription opioid use disorder (P‐OUD), in patients referred to specialised pain care.Methods: This cross‐sectional study utilised baseline data from a clinical chronic pain cohort. Eligible participants included adults > 18 years old, not undergoing cancer treatment, had pain > 3 months, and had been referred to a specialised pain care centre in Sweden. Bivariate logistic regression and multivariable logistic regression with forward selection were used to examine the associations between biopsychosocial variables and either long‐term opioid use or P‐OUD.Results: Of the 339 patients included, 194 (57%) were using opioids, 159 (47%) had long‐term opioid use (> 90 days), and 34 (21% of those with long‐term opioid use) had P‐OUD. Longer pain duration, unemployment, more pain catastrophising, lower health‐related quality of life, and worse balance increased the likelihood of long‐term opioid use. Long‐term use of high doses was associated with a greater prevalence of psychiatric and cognitive‐behavioural problems compared to long‐term use at low to moderate doses. Long‐term opioid use, younger age, trauma exposure, more pain catastrophising, and fear of movement increased the likelihood of P‐OUD.Conclusions: Our results demonstrate the importance of identifying and treating salient factors that may sustain both the pain condition and long‐term opioid use. Many of the biopsychosocial variables associated with long‐term opioid use and P‐OUD can be addressed within interdisciplinary pain management and rehabilitation programmes.Significance: This study is part of the U‐PAIN cohort study on a clinical sample from a highly specialised pain centre in Sweden. It is based on a deep and thorough characterisation of patients referred to the clinic to evaluate risks and benefits of opioid therapy in chronic pain. It adds valuable information on the complexity of opioid therapy in chronic pain; the results highlight the need for interdisciplinary multimodal evaluation and treatment.
- 19 July 2025
- Published by Wiley in European journal of pain
- Vol. 29 (7) , e70081
Open AccessOpioid Use and Prescription Opioid Use Disorder: Biopsychosocial Characterisation of a Clinical Chronic Pain Cohort
Background: This study aimed to examine: (a) characteristics associated with long‐term opioid use and (b) characteristics associated with problematic opioid use, here defined as prescription opioid use disorder (P‐OUD), in patients referred to specialised pain care.Methods: This cross‐sectional study utilised baseline data from a clinical chronic pain cohort. Eligible participants included adults > 18 years old, not undergoing cancer treatment, had pain > 3 months, and had been referred to a specialised pain care centre in Sweden. Bivariate logistic regression and multivariable logistic regression with forward selection were used to examine the associations between biopsychosocial variables and either long‐term opioid use or P‐OUD.Results: Of the 339 patients included, 194 (57%) were using opioids, 159 (47%) had long‐term opioid use (> 90 days), and 34 (21% of those with long‐term opioid use) had P‐OUD. Longer pain duration, unemployment, more pain catastrophising, lower health‐related quality of life, and worse balance increased the likelihood of long‐term opioid use. Long‐term use of high doses was associated with a greater prevalence of psychiatric and cognitive‐behavioural problems compared to long‐term use at low to moderate doses. Long‐term opioid use, younger age, trauma exposure, more pain catastrophising, and fear of movement increased the likelihood of P‐OUD.Conclusions: Our results demonstrate the importance of identifying and treating salient factors that may sustain both the pain condition and long‐term opioid use. Many of the biopsychosocial variables associated with long‐term opioid use and P‐OUD can be addressed within interdisciplinary pain management and rehabilitation programmes.Significance: This study is part of the U‐PAIN cohort study on a clinical sample from a highly specialised pain centre in Sweden. It is based on a deep and thorough characterisation of patients referred to the clinic to evaluate risks and benefits of opioid therapy in chronic pain. It adds valuable information on the complexity of opioid therapy in chronic pain; the results highlight the need for interdisciplinary multimodal evaluation and treatment.
- Open Access
- 20 May 2021
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Pain
- Vol. 21 (4) , 732-742
Psychometric assessment of the Swedish version of the injustice experience questionnaire among patients with chronic pain
Objectives: The use of the Injustice Experience Questionnaire (IEQ) in psychological assessment of individuals with chronic pain is supported by research. The psychometric properties of the Swedish version, the IEQ-S, has not yet been evaluated. Hence, the aim was to investigate structural validity, and concurrent criterion validity of the IEQ-S against the Work Ability Index (WAI), the Pain Catastrophizing Scale (PCS-SW), the Patient Health Questionnaire 9-item depression module (PHQ-9), and the Generalized anxiety disorder 7-item scale (GAD-7). Internal consistency and test-retest reliability were also studied. Methods: Sixty-five participants, referred to a University hospital, with a pain duration over three months were consecutively sampled. They completed the IEQ-S at admission and again within six weeks. A confirmatory factor analysis was performed for the study of structural validity. Concurrent criterion validity was evaluated using Spearman’s correlation coefficient. Internal consistency reliability for the full IEQ-S was calculated using the Cronbach’s alpha. Test-retest reliability was calculated using an Intraclass Correlation Coefficient (ICC). Results: The median total score (0–48, where high scores indicate high levels of injustice) at admission (test 1) was 27.0 (n=64), 25th percentile=15.3, 75th percentile=37.8, range=3–48 points. A one-factor model was supported with item-loadings between 0.67–0.92. Spearman’s correlation coefficient between the IEQ-S and the WAI (n=56) was r S =−0.46; the PCS-SW (n=63) was r S =0.68, the PHQ-9 (n=64) was r S =0.50 and the GAD-7 (n=64) was r S =0.57, p<0.01. Cronbach’s alpha was 0.94 (n=64). The ICC was 0.80 (n=55), with a 95% confidence interval, ranging between 0.69–0.88. Conclusions: Our study supported structural validity and concurrent criterion validity of the IEQ-S against other measures of psychological constructs and work ability. It also supported the internal consistency reliability of the IEQ-S and the test-retest reliability with a retest interval up to six weeks, was good. These findings support the use of the IEQ-S as an adjunct tool to assess appraisals of injustice in patients with chronic pain who are referred to tertiary care in Sweden. The added value might be identification of those who are at risk for slow or no improvement in their pain condition over time, and sick-leave, but this has to be confirmed in future studies. Ethical committee number: EPN Uppsala D-No 2016-376.
- 20 May 2021
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Pain
- Vol. 21 (4) , 732-742
Open AccessPsychometric assessment of the Swedish version of the injustice experience questionnaire among patients with chronic pain
Objectives: The use of the Injustice Experience Questionnaire (IEQ) in psychological assessment of individuals with chronic pain is supported by research. The psychometric properties of the Swedish version, the IEQ-S, has not yet been evaluated. Hence, the aim was to investigate structural validity, and concurrent criterion validity of the IEQ-S against the Work Ability Index (WAI), the Pain Catastrophizing Scale (PCS-SW), the Patient Health Questionnaire 9-item depression module (PHQ-9), and the Generalized anxiety disorder 7-item scale (GAD-7). Internal consistency and test-retest reliability were also studied. Methods: Sixty-five participants, referred to a University hospital, with a pain duration over three months were consecutively sampled. They completed the IEQ-S at admission and again within six weeks. A confirmatory factor analysis was performed for the study of structural validity. Concurrent criterion validity was evaluated using Spearman’s correlation coefficient. Internal consistency reliability for the full IEQ-S was calculated using the Cronbach’s alpha. Test-retest reliability was calculated using an Intraclass Correlation Coefficient (ICC). Results: The median total score (0–48, where high scores indicate high levels of injustice) at admission (test 1) was 27.0 (n=64), 25th percentile=15.3, 75th percentile=37.8, range=3–48 points. A one-factor model was supported with item-loadings between 0.67–0.92. Spearman’s correlation coefficient between the IEQ-S and the WAI (n=56) was r S =−0.46; the PCS-SW (n=63) was r S =0.68, the PHQ-9 (n=64) was r S =0.50 and the GAD-7 (n=64) was r S =0.57, p<0.01. Cronbach’s alpha was 0.94 (n=64). The ICC was 0.80 (n=55), with a 95% confidence interval, ranging between 0.69–0.88. Conclusions: Our study supported structural validity and concurrent criterion validity of the IEQ-S against other measures of psychological constructs and work ability. It also supported the internal consistency reliability of the IEQ-S and the test-retest reliability with a retest interval up to six weeks, was good. These findings support the use of the IEQ-S as an adjunct tool to assess appraisals of injustice in patients with chronic pain who are referred to tertiary care in Sweden. The added value might be identification of those who are at risk for slow or no improvement in their pain condition over time, and sick-leave, but this has to be confirmed in future studies. Ethical committee number: EPN Uppsala D-No 2016-376.